Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04350827 · ClinicalTrials.gov registry record · NA
PRP vs PRP Plus IGF for Patellar Tendinosis
A NA study of Tendinopathy and Patellar Ligament, sponsored by Ohio State University.
- Completed
- Registry status
- NA
- Development phase
- 14
- Enrollment target
- 1
- Study location
NCT04350827: Completed NA study of Tendinopathy and Patellar Ligament, sponsored by Ohio State University.
NCT04350827 is a NA study of Tendinopathy and Patellar Ligament that has completed, run by Ohio State University. The registered enrollment target is 14 participants, below the 1,065-participant average among 10 other Tendinopathy trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04350827, a NA study of Tendinopathy and Patellar Ligament, has completed, sponsored by Ohio State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to compare two different platelet-rich plasma (PRP) injections for patellar tendinosis. Aim: To perform a randomized, double blinded study comparing the clinical effect of PRP versus PRP + concentrated insulin-like growth factor (IGF) in patients with patellar tendinosis.
Primary Outcome
Victorian Institute of sport assessment scale for patellar tendinopathy \[VISA-P\] is a self-administered questionnaire consisting of 8 items; 6 are used to evaluate pain levels or disability in daily activities and specific functional tests and 2 provide information regarding ability to play sport. The maximum score possible is 100 points and represents an asymptomatic athlete who can fully engage in sports. The theoretical minimum is 0 points.
Conditions Studied
Interventions
- DEVICE Platelet Rich Plasma
- DEVICE Platelet Rich Plasma plus IGF
Study Locations (1)
Ohio
- The Ohio State University Sports Medicine Center - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2020-02-25 |
| Est. Completion | 2021-10-16 |
| Phase | NA |
What the finished NCT04350827 record still lists
NCT04350827 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 14 participants, a relatively small participant target, below the 1,065-participant average among 10 other Tendinopathy trials with a reported enrollment target (99% lower).
The record links to 3 conditions, with Tendinopathy appearing as the primary indexed condition, and to 2 interventions - of which Platelet Rich Plasma is the first listed.
NCT04350827 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT04350827 about?
NCT04350827 is a clinical study titled "PRP vs PRP Plus IGF for Patellar Tendinosis". The purpose of this study is to compare two different platelet-rich plasma (PRP) injections for patellar tendinosis. Aim: To perform a randomized, double blinded study comparing the clinical effect of PRP versus PRP + concentrated insulin-like growth factor (IGF) in patients with patellar tendinosi...
What is the current status of trial NCT04350827?
This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2020-02-25. Estimated completion is 2021-10-16.
What conditions does trial NCT04350827 study?
This clinical trial studies the following conditions: Tendinopathy, Patellar Ligament, Platelet-Rich Plasma.
What interventions are being tested in trial NCT04350827?
The interventions under investigation include: Platelet Rich Plasma (DEVICE), Platelet Rich Plasma plus IGF (DEVICE).
Who is sponsoring clinical trial NCT04350827?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04350827 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tendinopathy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04350827's enrollment target sits among peer trials
14 11th of 10 the lowest of 10 other Tendinopathy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Tendinopathy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Platelet Rich Plasma for Musculoskeletal Conditions
RECRUITING · NA
-
Embolization Treatment of Chronic Refractory Shoulder Tendinopathy
RECRUITING · NA
-
Long Duration Therapeutic Ultrasound for Tendon Healing
COMPLETED · NA
-
Achilles Tendon Repair With Bioinductive Implant
COMPLETED · NA
-
Ketorolac in Upper Extremity Tendinopathy and Arthropathy
RECRUITING · Phase 4
-
Assessing the Tendons With Shear Wave Elastography
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523092 · 14 participants · Phase 4
Use of CXCL9 as a Biomarker of Acthar Efficacy
- NCT04263285 · 14 participants · NA
Treatment of Depression Post-SCI
- NCT04743271 · 14 participants · NA
Food and Circadian Timing
- NCT05065671 · 14 participants · Phase 1
Microbiome Derived Metabolism and Pharmacokinetics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy